Purpose-driven values, low administration costs and efficient fundraising methods are the way we accomplish our non-profit organisation work.
The Foundation brings together motivated and passionate individuals who are dedicated to improving the lives of children affected by cancer. This passion has raised over $60.5 million which has been spent on a range of projects big and small.
Much of the $13.3m we have spent on research initiatives has been focused on broadening our knowledge of childhood cancer and investing in bright minds to enhance the “bench strength” of Australia childhood cancer researchers, clinical oncologists, nurses and allied health workers.
The state wide Bone Marrow Transplant unit at the Royal Children’s Hospital achieved international accreditation and access to international exchanges through our $3.7m contribution from 2006 to 2012.
In 2017 we partnered with Hudson Monash Research Institute to create a Paediatric Precision Medicine Program. Our investment of $6.2m hopes to significantly improve treatment for childhood cancer patients with the greatest unmet clinical need – those diagnosed with brain cancers and solid tumours.
We have invested over $11.7m funding clinical care activities to demonstrate that they make a difference. We have funded the following activities well before most were considered “basic services” – Art, Music and Play Therapy, Physiotherapy, Dietitians, Social Workers, Psychologists, Pharmacy Services and Nurser Educators and Co-ordinators.
In 2004 we funded the $22m reconstruction of the cancer ward and the research facilities at the former Royal Children Hospital and Murdoch Children’s Research Institute sites. Whilst the buildings might have been demolished, the learning and experience of this investment affected the DNA of the current children’s cancer facilities.
In 2008 we invested in our first clinical trial to help children secure better treatment. Thus far we have spent more than $3m on or supporting clinical trials providing hope and access to global pathways for some of the most challenging cancers.